Report Detail
Global Multiple Sclerosis Drugs Market Size, Status and Forecast 2019-2025
- RnM2740062 |
- 28 June, 2019 |
- Global |
- 94 Pages |
- QYResearch |
- Other
Multiple sclerosis (MS) is a nervous system disease which affects spinal cord and the brain. MS damages the myelin sheath. Myelin sheath is a term which exemplifies that material which surrounds and protects human nerve cells. This damage blocks messages between brain and the body and leads to the symptoms of MS. Some of the major symptoms of MS include thinking and memory problems, visual disturbances, problem in coordination and balancing of the body and muscle weakness.
MS affects women more than men. The disease often occurs between age group of 20-40. MS is mainly divided into four types. They are relapsing-remitting MS, progressive-relapsing MS, secondary-progressive MS and primary-progressive MS. Relapsing-remitting MS is the most common form of the disease. It accounts about 85% of the total MS cases. Secondary-progressive is associated with the initial period of relapsing-remitting disease. Approximately, 50% of people suffering with relapsing remitting MS would develop this form of the disease. Progressive-relapsing MS is rare and about 5% of the total MS cases. Primary-progressive MS accounts 10% of the total MS cases.
In terms of geographic, North America dominates the global MS drugs market. The U.S. represents the largest market for MS drugs followed by Canada in North America. In Europe, France, Germany, Italy, Spain and the U.K. holds major share of MS drugs market. However, Asia is expected to show high growth rates in the next five years in global MS drugs market. This is due to many companies constructing their manufacturing and research facilities in the region. Developing regions have advantage over the developed regions due to low wages, availability of a large talent pool, less stringent environment and health and safety regulations. Japan, China and India are expected to be the fastest growing MS drugs markets in Asia.
In 2018, the global Multiple Sclerosis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Multiple Sclerosis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Sclerosis Drugs development in United States, Europe and China.
The key players covered in this study
GlaxoSmithKline
Novartis
Merck
Sanofi
Pfizer
Bayer
Teva Pharmaceutical
Abbvie
Biogen Idec
AB Science
Opexa
Market segment by Type, the product can be split into
Oral Drugs
Parenteral Drugs
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Multiple Sclerosis Drugs status, future forecast, growth opportunity, key market and key players.
To present the Multiple Sclerosis Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Multiple Sclerosis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Multiple Sclerosis Drugs Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Oral Drugs
- 1.4.3 Parenteral Drugs
- 1.5 Market by Application
- 1.5.1 Global Multiple Sclerosis Drugs Market Share by Application (2014-2025)
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Online Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Multiple Sclerosis Drugs Market Size
- 2.2 Multiple Sclerosis Drugs Growth Trends by Regions
- 2.2.1 Multiple Sclerosis Drugs Market Size by Regions (2014-2025)
- 2.2.2 Multiple Sclerosis Drugs Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Multiple Sclerosis Drugs Market Size by Manufacturers
- 3.1.1 Global Multiple Sclerosis Drugs Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Multiple Sclerosis Drugs Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Multiple Sclerosis Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Multiple Sclerosis Drugs Key Players Head office and Area Served
- 3.3 Key Players Multiple Sclerosis Drugs Product/Solution/Service
- 3.4 Date of Enter into Multiple Sclerosis Drugs Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Multiple Sclerosis Drugs Market Size by Type (2014-2019)
- 4.2 Global Multiple Sclerosis Drugs Market Size by Application (2014-2019)
5 United States
- 5.1 United States Multiple Sclerosis Drugs Market Size (2014-2019)
- 5.2 Multiple Sclerosis Drugs Key Players in United States
- 5.3 United States Multiple Sclerosis Drugs Market Size by Type
- 5.4 United States Multiple Sclerosis Drugs Market Size by Application
6 Europe
- 6.1 Europe Multiple Sclerosis Drugs Market Size (2014-2019)
- 6.2 Multiple Sclerosis Drugs Key Players in Europe
- 6.3 Europe Multiple Sclerosis Drugs Market Size by Type
- 6.4 Europe Multiple Sclerosis Drugs Market Size by Application
7 China
- 7.1 China Multiple Sclerosis Drugs Market Size (2014-2019)
- 7.2 Multiple Sclerosis Drugs Key Players in China
- 7.3 China Multiple Sclerosis Drugs Market Size by Type
- 7.4 China Multiple Sclerosis Drugs Market Size by Application
8 Japan
- 8.1 Japan Multiple Sclerosis Drugs Market Size (2014-2019)
- 8.2 Multiple Sclerosis Drugs Key Players in Japan
- 8.3 Japan Multiple Sclerosis Drugs Market Size by Type
- 8.4 Japan Multiple Sclerosis Drugs Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Multiple Sclerosis Drugs Market Size (2014-2019)
- 9.2 Multiple Sclerosis Drugs Key Players in Southeast Asia
- 9.3 Southeast Asia Multiple Sclerosis Drugs Market Size by Type
- 9.4 Southeast Asia Multiple Sclerosis Drugs Market Size by Application
10 India
- 10.1 India Multiple Sclerosis Drugs Market Size (2014-2019)
- 10.2 Multiple Sclerosis Drugs Key Players in India
- 10.3 India Multiple Sclerosis Drugs Market Size by Type
- 10.4 India Multiple Sclerosis Drugs Market Size by Application
11 Central & South America
- 11.1 Central & South America Multiple Sclerosis Drugs Market Size (2014-2019)
- 11.2 Multiple Sclerosis Drugs Key Players in Central & South America
- 11.3 Central & South America Multiple Sclerosis Drugs Market Size by Type
- 11.4 Central & South America Multiple Sclerosis Drugs Market Size by Application
12 International Players Profiles
- 12.1 GlaxoSmithKline
- 12.1.1 GlaxoSmithKline Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Multiple Sclerosis Drugs Introduction
- 12.1.4 GlaxoSmithKline Revenue in Multiple Sclerosis Drugs Business (2014-2019)
- 12.1.5 GlaxoSmithKline Recent Development
- 12.2 Novartis
- 12.2.1 Novartis Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Multiple Sclerosis Drugs Introduction
- 12.2.4 Novartis Revenue in Multiple Sclerosis Drugs Business (2014-2019)
- 12.2.5 Novartis Recent Development
- 12.3 Merck
- 12.3.1 Merck Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Multiple Sclerosis Drugs Introduction
- 12.3.4 Merck Revenue in Multiple Sclerosis Drugs Business (2014-2019)
- 12.3.5 Merck Recent Development
- 12.4 Sanofi
- 12.4.1 Sanofi Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Multiple Sclerosis Drugs Introduction
- 12.4.4 Sanofi Revenue in Multiple Sclerosis Drugs Business (2014-2019)
- 12.4.5 Sanofi Recent Development
- 12.5 Pfizer
- 12.5.1 Pfizer Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Multiple Sclerosis Drugs Introduction
- 12.5.4 Pfizer Revenue in Multiple Sclerosis Drugs Business (2014-2019)
- 12.5.5 Pfizer Recent Development
- 12.6 Bayer
- 12.6.1 Bayer Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Multiple Sclerosis Drugs Introduction
- 12.6.4 Bayer Revenue in Multiple Sclerosis Drugs Business (2014-2019)
- 12.6.5 Bayer Recent Development
- 12.7 Teva Pharmaceutical
- 12.7.1 Teva Pharmaceutical Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Multiple Sclerosis Drugs Introduction
- 12.7.4 Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Business (2014-2019)
- 12.7.5 Teva Pharmaceutical Recent Development
- 12.8 Abbvie
- 12.8.1 Abbvie Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Multiple Sclerosis Drugs Introduction
- 12.8.4 Abbvie Revenue in Multiple Sclerosis Drugs Business (2014-2019)
- 12.8.5 Abbvie Recent Development
- 12.9 Biogen Idec
- 12.9.1 Biogen Idec Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Multiple Sclerosis Drugs Introduction
- 12.9.4 Biogen Idec Revenue in Multiple Sclerosis Drugs Business (2014-2019)
- 12.9.5 Biogen Idec Recent Development
- 12.10 AB Science
- 12.10.1 AB Science Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Multiple Sclerosis Drugs Introduction
- 12.10.4 AB Science Revenue in Multiple Sclerosis Drugs Business (2014-2019)
- 12.10.5 AB Science Recent Development
- 12.11 Opexa
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Multiple Sclerosis Drugs . Industry analysis & Market Report on Multiple Sclerosis Drugs is a syndicated market report, published as Global Multiple Sclerosis Drugs Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Multiple Sclerosis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
